These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 6139800)

  • 121. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 122. [Systemic arterial hypertension: pathogentic role of the sympathetic nervous system].
    Andrejak M; Simon A; Hardin JM; Fournier A; Safar M; Quichaud J
    Nouv Presse Med; 1977 Dec; 6(42):3963-7. PubMed ID: 600739
    [TBL] [Abstract][Full Text] [Related]  

  • 123. [Vascular changes in essential hypertension after treatment with enalapril].
    Dusek J; Siegelová J; Prikryl P; Kunovská V; Mayer P
    Vnitr Lek; 1989 Nov; 35(11):1079-86. PubMed ID: 2560283
    [TBL] [Abstract][Full Text] [Related]  

  • 124. [Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension].
    Philipp T
    Fortschr Med; 1979 Aug; 97(30-31):1315-20. PubMed ID: 468094
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 126. [Long-term therapy with beta receptor blockaders].
    Bühler FR
    Z Gesamte Inn Med; 1981 Mar; 36(6):283-8 suppl. PubMed ID: 6114598
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.
    van Baak MA; Kho TL; Thijssen H; Rahn KH
    Eur J Clin Pharmacol; 1982; 23(5):377-82. PubMed ID: 6759143
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Indications for beta-adrenoceptor blocking drugs in hypertension.
    Lorimer AR; Jones JV; Clark B; Dunn FG; Melville D; Lawrie TD
    Postgrad Med J; 1976; 52 Suppl 4():81-5. PubMed ID: 9635
    [TBL] [Abstract][Full Text] [Related]  

  • 129. beta-Adrenoceptor blockers in the treatment of hypertension.
    Falase AO; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):13-8. PubMed ID: 45432
    [TBL] [Abstract][Full Text] [Related]  

  • 130. [Antihypertensive therapy using beta receptor blockers].
    Meurer KA
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2161-2. PubMed ID: 240664
    [No Abstract]   [Full Text] [Related]  

  • 131. Enhanced exercise noradrenaline concentrations during propranolol treatment: a limiting factor in cardiac beta-adrenoceptor blockade.
    Hurwitz GA; Webb JG; Walle T; Gourley LA; Cobb L
    Can J Cardiol; 1988 Sep; 4(6):262-9. PubMed ID: 2846132
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats.
    Davy M; Midol-Monnet M; Heimburger M; Wepierre J; Cohen Y
    J Pharmacol; 1986; 17(1):28-36. PubMed ID: 2872366
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Proceedings: The effects of beta-adrenergic blockade upon the cardiovascular responses of the rat to noradrenaline infusions.
    Imms FJ; Neame RL; Powis DA
    J Physiol; 1974 Aug; 241(1):47P-49P. PubMed ID: 4153711
    [No Abstract]   [Full Text] [Related]  

  • 134. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
    Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M
    Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
    Andersen GS; Hartling OJ; Hein HO; Leth A
    Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise.
    Parfyonova EV; Korichneva IL; Suvorov YI; Krasnikova TL
    Health Psychol; 1988; 7 Suppl():33-52. PubMed ID: 2854050
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Maiwald C
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):597-604. PubMed ID: 2905341
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension.
    Tham TC; Silke B; Taylor SH
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():77-83. PubMed ID: 2370647
    [TBL] [Abstract][Full Text] [Related]  

  • 140. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.